Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation 2024-09-27 19:00
Anbogen Announces Drug Supply Collaboration with BeiGene to Evaluate Combination Therapy in Colorectal Cancer 2024-09-27 16:00
IASO Bio Presented the Outcomes of Relapsed/Refractory Multiple Myeloma (R/RMM) Patients with Renal Impairment Treated with Equecabtagene Autoleucel (Fucaso™) at 2024 IMS Annual Meeting 2024-09-27 15:41
ArkBio Announces Publication of Phase 3 Clinical Trial Results of Ziresovir for the Treatment of RSV Infection in The New England Journal of Medicine 2024-09-26 20:28
Breakthrough Therapy Designation (BTD) for BioCity's SC0062, a selective endothelin type A (ETA) antagonist, granted by National Medical Products Administration for IgA nephropathy (IgAN) with proteinuria 2024-09-26 15:10
Vanderbilt University School of Medicine Basic Sciences Adds Carterra's LSAXT Instrument to Speed Drug and Vaccine Research and Advance Patient Care 2024-09-25 22:02
The World First Liquid Formulation of Recombinant Botulinum Toxin Type A Has Obtained IND Approval by the FDA 2024-09-25 21:18
CariGenetics And One BioMed Strike Partnership to Advance Genomic Testing in the Caribbean - Decentralised Approach Serves the Needs of the Caribbean Community 2024-09-25 19:00
Samsung Biologics launches development platforms for enhanced therapeutic efficacy 2024-09-25 19:00
Belief BioMed to Collaborate with AskBio to Explore the Potential of New Gene Therapies 2024-09-25 14:58
Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024 2024-09-25 13:21
EADV Congress 2024: Semaglutide improves outcomes for obese patients with common skin condition, new study shows 2024-09-25 06:01
EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment 2024-09-24 23:37
LongBio announced the completion of Series B2 financing, led by Qiming Venture Partners 2024-09-24 21:00
Nona Biosciences Enters Strategic Collaboration with Alkyon Therapeutics for Next-Generation Immunotherapeutics Discovery 2024-09-24 20:00
Veltassa® (patiromer) approved in Japan for the treatment of adults with hyperkalemia 2024-09-24 15:30
Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Thailand 2024-09-23 17:42
Impressive preliminary objective response rates (ORR) of 36% in NSCLC and 80% in EGFRmut NSCLC: Interim Results of a Phase 1 Study of BC3195, a First-in-Class ADC Targeting CDH3, Presented by BioCity at ESMO 2024 2024-09-23 17:40
WuXi Biologics Included in Hang Seng ESG 50 Index 2024-09-23 17:30
Nuance Pharma Announces Expansion of Bentrio License and Distribution Agreement with Altamira Therapeutics in East and South East Asia 2024-09-23 15:00
1 17 18 19 20 21 458